🇺🇸 PIEMONTE in United States

37 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 23 April 2025 – 23 April 2026
• Total reports: 37

Most-reported reactions

1. Asthmatic Crisis — 6 reports (16.22%)
2. Pruritus — 5 reports (13.51%)
3. Fatigue — 4 reports (10.81%)
4. Weight Decreased — 4 reports (10.81%)
5. Abdominal Pain — 3 reports (8.11%)
6. Chronic Obstructive Pulmonary Disease — 3 reports (8.11%)
7. Dyspnoea — 3 reports (8.11%)
8. Gait Inability — 3 reports (8.11%)
9. Malaise — 3 reports (8.11%)
10. Off Label Use — 3 reports (8.11%)

Source database →

Frequently asked questions

Is PIEMONTE approved in United States?

PIEMONTE does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for PIEMONTE in United States?

EMS is the originator. The local marketing authorisation holder may differ — check the official source linked above.